Press releases

2020 2019 2018 2017 2016 2015 2014 2013 2012
2020-09-23 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion avser att genomföra en riktad nyemission av aktier
2020-09-23 17:31
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion intends to carry out a directed issue of shares
2020-09-23 17:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion förvärvar det nederländska medicintekniska företaget Organ Assist och finansierar förvärvet genom en nyemission av aktier
2020-09-23 17:30
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion to acquire the Dutch medtech company Organ Assist and finances the acquisition through a private placement of new shares
2020-09-21 16:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
Changes in XVIVO Perfusion's Management Team
2020-09-21 16:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Förändringar i XVIVO Perfusions ledningsgrupp
2020-09-11 16:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till extra bolagsstämma i XVIVO Perfusion AB (publ)
2020-09-11 16:15
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice to attend the Extraordinary General Meeting in XVIVO Perfusion AB (publ)
2020-09-09 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Första patienten i PrimECC-studien inkluderad
2020-09-09 07:30
News
IR
English
Corporate Information
Other Corporate Information
First patient in the PrimECC study included
2020-09-04 11:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion stärker ledningsgruppen med ny Commercial Director och ny R&D Director
2020-09-04 11:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director
2020-07-10 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
I startblocken inför studieuppstart för hjärtpreservation och PrimECC
2020-07-10 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
In the starting blocks for heart preservation and PrimECC trial
2020-07-02 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2020-07-02 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2020-06-12 16:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Hjärtpreservations-studien från Lund publicerad i Nature Communications
2020-06-12 16:30
News
IR
English
Corporate Information
Other Corporate Information
The study from Lund published in Nature Communications
2020-05-19 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XPS™ säljs till en ledande lungtransplantationsklinik i Europa
2020-05-19 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XPS™ sold to a leading lung transplant clinic in Europe
2020-04-28 18:30
News
IR
English
Regulatory
MAR
Corporate Information
Staff change
Magnus Nilsson hands over the baton to Dag Andersson as President and CEO of XVIVO Perfusion
2020-04-28 18:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Staff change
Magnus Nilsson lämnar över stafettpinnen till Dag Andersson som vd och koncernchef för XVIVO Perfusion
2020-04-24 15:40
News
IR
Swedish
Corporate Information
Staff change
XVIVO utnämner ny IP-chef och ny Medicinsk chef
2020-04-24 15:40
News
IR
Swedish
Corporate Information
Staff change
XVIVO appoints a new IP manager and a new Medical Director
2020-04-09 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
Strong cash flow despite the influence of Covid-19
2020-04-09 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Starkt kassaflöde trots påverkan av Covid-19
2020-04-06 11:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport (uppdaterad länk)
2020-04-06 11:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report (link updated)
2020-04-02 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2020-04-02 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Conference call on Interim Report
2020-03-31 17:00
News
IR
Swedish
Regulatory
MAR
VPML
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2020-03-31 17:00
News
IR
English
Regulatory
MAR
VPML
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2020-03-31 09:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XPS™ såld till pediatrisk transplantationsklinik i Italien
2020-03-31 09:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XPS™ sold to pediatric transplantation clinic in Italy
2020-03-25 10:50
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Valberedningen föreslår oförändrade styrelsearvoden – justerad version
2020-03-25 10:50
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
The Nomination Committee proposes unchanged Board remuneration -adjusted version
2020-03-25 10:15
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
The Nomination Committee proposes unchanged Board remuneration
2020-03-25 10:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Valberedningen föreslår oförändrade styrelsearvoden
2020-03-25 08:30
News
IR
English
Regulatory
MAR
VPML
Corporate Information
Financial calendar
XVIVO Perfusion advances the date for submission of the January-March 2020 interim report
2020-03-25 08:30
News
IR
Swedish
Regulatory
MAR
VPML
Corporate Information
Financial calendar
XVIVO Perfusion tidigarelägger datum för avlämnande av delårsrapport för Januari-Mars 2020
2020-03-18 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Med anledning av Covid-19: XVIVO Perfusion AB:s årsstämma flyttas till ny adress och ytterligare försiktighetsåtgärder vidtas
2020-03-18 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
As a result of Covid-19: The Annual General Meeting of XVIVO Perfusion is moved to a new address and further precautions are taken
2020-03-18 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
COVID-19 EPIDEMINS PÅVERKAN PÅ XVIVO PERFUSION
2020-03-18 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
THE COVID-19 EFFECT ON XVIVO PERFUSION
2020-03-09 09:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2019
2020-03-09 09:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2019
2020-02-24 23:45
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice to attend the Annual General Meeting of XVIVO Perfusion AB (publ)
2020-02-24 23:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2020-01-30 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Yearend
A historic year ended with a quarter of sales records
2020-01-30 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Yearend
Kvartal med försäljningsrekord avslutar ett historiskt år
2020-01-24 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2020-01-24 08:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2019-12-16 11:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion har fått Breakthrough Device Designation beviljat från FDA för XVIVO Heart Preservation System
2019-12-16 11:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion granted Breakthrough Device Designation from the FDA for the XVIVO Heart Preservation System
2019-10-29 13:00
News
IR
English
Corporate Information
Other Corporate Information
Third XPS™ sold in Australia
2019-10-29 13:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Tredje XPS™ till i Australien
2019-10-24 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
Good growth and new important XPS clinics
2019-10-24 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
God tillväxt och viktiga nya XPS-kliniker
2019-10-23 16:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO opens a subsidiary in Australia
2019-10-23 16:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO öppnar ett dotterbolag i Australien
2019-10-23 13:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion AB (publ) issue of warrants of series 2019/2021 fully subscribed
2019-10-23 13:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion AB (publ) teckningsoptioner av serie 2019/2021 fulltecknat
2019-10-21 13:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2019-10-21 13:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2019-09-24 15:30
News
IR
Swedish
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2019-09-24 15:30
News
IR
English
Corporate Information
Nomination Committee
Nomination Committee of XVIVO Perfusion AB (publ)
2019-09-18 08:00
News
IR
English
Corporate Information
Other Corporate Information
XPS™ sold to China
2019-09-18 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XPS™ såld till Kina
2019-08-23 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Lung Bioengineering har köpt en XPS™ till deras nya EVLP center i Jacksonville
2019-08-23 08:00
News
IR
English
Corporate Information
Other Corporate Information
Lung Bioengineering has acquired the XPS™ for use in its new Jacksonville EVLP center
2019-08-21 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Perfadex® Plus has received patent approval in Europe
2019-08-21 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Perfadex Plus har erhållit patentgodkännande i Europa
2019-07-17 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO och MyCartis samarbetar inom utveckling av ett diagnostiskt test för att bedöma kvaliteten på donerade organ före transplantation
2019-07-17 08:30
News
IR
English
Corporate Information
Other Corporate Information
XVIVO and MyCartis engage to develop a fast diagnostic test to assess the quality of donated organs before transplantation
2019-07-12 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
HISTORISKT PMA-GODKÄNNANDE OCH FRAMSTEG I FoU-PORTFÖLJEN
2019-07-12 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
HISTORIC PMA APPROVAL AND PROGRESS IN THE R&D PORTFOLIO
2019-07-05 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2019-07-05 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2019-06-25 08:00
News
IR
English
Regulatory
VPML
Corporate Information
Financial calendar
XVIVO Perfusion changes the date of reporting of the Report on Operations 2019 to January 30, 2020
2019-06-25 08:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Financial calendar
XVIVO Perfusion tidigarelägger datum för rapportering av Bokslutskommuniké 2019 till den 30:e januari 2020.
2019-05-31 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2019-05-31 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2019-05-15 08:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO har erhållit klartecken från läkemedelsverket för kliniska studier med bolagets nya produkter för hjärtpreservation
2019-05-15 08:00
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO has received approval from the Swedish MPA to begin clinical studies with the company's new products for heart preservation
2019-05-03 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Första XPS™ såld till Kanada
2019-05-03 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
First XPS™ sold to Canada
2019-05-02 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVOs patent för hjärtpreservations-vätska godkända i USA och Europa
2019-05-02 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO’s patents for the heart preservation fluid approved in the US and Europe
2019-04-29 08:30
News
IR
English
Corporate Information
Other Corporate Information
XVIVO has received market approval (PMA) from the FDA for STEEN Solution™ and XPS™
2019-04-29 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO har erhållit marknadsgodkännande (PMA) för STEEN Solution™ och XPS™ av FDA
2019-04-27 00:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO has received market approval (PMA) from the FDA for STEEN Solution™ and XPS™
2019-04-27 00:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO har erhållit marknadsgodkännande (PMA) för STEEN Solution™ och XPS™ av FDA
2019-04-25 16:30
News
IR
English
Regulatory
MAR
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2019-04-25 16:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2019-04-24 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
STRONG GROWTH IN WARM PERFUSION AND PROGRESS IN THE R&D PORTFOLIO
2019-04-24 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
HÖG TILLVÄXT FÖR VARM PERFUSION OCH FRAMSTEG INOM FoU-PORTFÖLJEN
2019-04-23 17:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Resultat från hjärtpreservations-studien presenterat på ISHLT
2019-04-23 17:00
News
IR
English
Corporate Information
Other Corporate Information
Results from the heart preservation study presented on ISHLT
2019-04-16 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2019-04-16 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2019-04-02 12:00
News
IR
English
Regulatory
VPML
Report
Annual
Annual Report 2018
2019-04-02 12:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2018
2019-03-25 14:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
RÄTTELSE AV KALLELSE TILL ÅRSSTÄMMA I XVIVO PERFUSION AB (publ)
2019-03-25 14:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
AMENDMENT OF NOTICE TO ATTEND ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (publ)
2019-03-25 06:00
News
IR
Swedish
Corporate Information
Other Corporate Information
VD Magnus Nilsson har kvar lika många aktier som innan den 6 mars 2019
2019-03-25 06:00
News
IR
English
Corporate Information
Other Corporate Information
CEO Magnus Nilsson has the same number of shares as before March 6, 2019
2019-03-20 09:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2019-03-20 09:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2019-02-08 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion AB (publ) Bokslutskommuniké 2018
2019-02-08 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion AB (publ) Report on operations 2018
2019-02-04 11:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2019-02-04 11:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2019-01-15 16:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Information from XVIVO Perfusion´s Nomination Committee
2019-01-15 16:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Information från XVIVO Perfusions Valberedning
2018-12-07 13:30
News
IR
English
Corporate Information
Other Corporate Information
Professor Stig Steen’s heart preservation technology required for successful transplantation from pigs to baboons
2018-12-07 13:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Professor Stig Steens hjärtpreservationsteknologi en förutsättning för lyckade hjärttransplantationer från gris till babian
2018-10-26 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion AB (publ) delårsrapport januari – september 2018
2018-10-26 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion AB (publ) Interim Report January – September 2018
2018-10-17 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2018-10-17 15:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2018-09-24 15:30
News
IR
English
Corporate Information
Nomination Committee
Nomination Committee of XVIVO Perfusion AB (publ)
2018-09-24 15:30
News
IR
Swedish
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2018-07-20 08:00
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
Interim report January-June 2018
2018-07-20 08:00
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
Delårsrapport januari-juni 2018
2018-07-12 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2018-07-12 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2018-06-29 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2018-06-29 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2018-06-25 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Perfadex Plus godkänt av FDA
2018-06-25 10:00
News
IR
English
Corporate Information
Other Corporate Information
Perfadex Plus approved by the FDA
2018-06-14 20:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion changes the date of reporting of the interim report January - June 2018 to July 20, 2018
2018-06-14 20:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion ändrar datum för rapportering av delårsrapport januari – juni 2018 till den 20 juli 2018
2018-06-12 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
UNITED THERAPEUTICS OCH XVIVO PERFUSION INLEDER SAMARBETE FÖR ATT MINSKA ORGANBRISTEN GENOM UTÖKAD TJÄNST INOM ORGANUTVÄRDERING
2018-06-12 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
UNITED THERAPEUTICS AND XVIVO PERFUSION ANNOUNCE COLLABORATION TO REDUCE ORGAN SHORTAGE THROUGH EXPANSION OF ORGAN EVALUATION SERVICE
2018-06-05 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Xvivo Perfusion lanserar Perfadex Plus, en uppgraderad ready to use version av Perfadex
2018-06-05 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO Perfusion launches Perfadex Plus, an upgraded ready to use version of Perfadex
2018-05-14 14:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Positiva fynd i PrimECC®-studien
2018-05-14 14:00
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Positive findings in the PrimECC study
2018-05-11 06:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
PMA ansökan för STEEN Solution™ och XPS™ inlämnad till FDA
2018-05-11 06:00
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
PMA application for XPS™ with STEEN Solution™ submitted to the FDA
2018-04-27 14:40
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2018-04-27 14:40
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2018-04-26 07:00
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
XVIVO Perfusion AB (publ) delårsrapport januari – mars 2018
2018-04-26 07:00
News
IR
English
Regulatory
MAR
Report
Interim
Q1
XVIVO Perfusion AB (publ) Interim Report January – March 2018
2018-04-19 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2018-04-19 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2018-04-04 12:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2017
2018-04-04 12:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2017
2018-03-22 09:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2018-03-22 09:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2018-03-22 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Optionsprogram till VD och vice VD/CFO
2018-03-22 08:30
News
IR
English
Corporate Information
Other Corporate Information
Option program for the CEO and the deputy CEO
2018-03-08 15:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Information från XVIVO Perfusions Valberedning
2018-03-08 15:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Information from XVIVO Perfusion´s Nomination Committee
2018-02-09 08:00
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion AB (publ) Bokslutskommuniké 2017
2018-02-09 08:00
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion AB (publ) Report on Operations 2017
2018-02-05 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Ändrat datum för Telefonkonferens avseende bokslutskommuniké
2018-02-05 09:00
News
IR
English
Corporate Information
Other Corporate Information
Date changed for Conference call on Report on Operations
2018-02-01 15:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2018-02-01 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2017-12-01 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Första XPS™ installerad i Kina
2017-12-01 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
First XPS™ installed in China
2017-11-07 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Reimbursement-koder erhållna för hela EVLP processen i USA
2017-11-07 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Reimbursement codes obtained for doctor´s time during EVLP procedure
2017-10-27 08:00
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion (publ) Interim Report January – September 2017
2017-10-27 08:00
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion AB (publ) delårsrapport januari – september 2017
2017-10-20 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2017-10-20 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2017-09-21 14:30
News
IR
Swedish
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2017-09-21 14:30
News
IR
English
Corporate Information
Nomination Committee
Nomination Committee of XVIVO Perfusion AB (publ)
2017-09-12 14:40
News
IR
Swedish
Corporate Information
Other Corporate Information
Första hjärttransplantationen med Stig Steens nya metod genomförd på människa
2017-09-12 14:40
News
IR
English
Corporate Information
Other Corporate Information
First clinical heart transplant performed using Stig Steen’s new method
2017-07-17 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
XVIVO Perfusion´s CFO appointed Deputy CEO
2017-07-17 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
XVIVO Perfusions CFO utnämnd till vice VD
2017-07-14 08:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
Interim Report January – June 2017
2017-07-14 08:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
Delårsrapport januari – juni 2017
2017-07-13 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
PrimECC studien färdigrekryterad
2017-07-13 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Recruitment completed for PrimECC study
2017-07-10 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2017-07-10 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2017-07-06 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Recruitment completed for NOVEL study in the US on STEEN Solution™ and XPS™
2017-07-06 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
NOVEL-studien i USA med STEEN Solution™ och XPS™ färdigrekryterad
2017-06-30 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2017-06-30 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2017-04-28 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2017-04-28 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2017-04-26 17:17
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2017-04-26 17:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2017-04-25 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Delårsrapport januari – mars 2017
2017-04-25 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
Interim Report January – March 2017
2017-04-19 09:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2017-04-19 09:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2017-04-12 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
First XPS™ sold to Australia and to the Netherlands
2017-04-12 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Australien och Nederländerna nya länder med XPS™
2017-04-10 09:45
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
SUMMARY FROM EXTRAORDINARY GENERAL MEETING OF XVIVO PERFUSION AKTIEBOLAG (PUBL)
2017-04-10 09:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I XVIVO PERFUSION AKTIEBOLAG (PUBL)
2017-04-04 07:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2016
2017-04-04 07:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2016
2017-03-20 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2017-03-20 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2017-03-17 07:35
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice of Extraordinary General Meeting of XVIVO Perfusion Aktiebolag (publ)
2017-03-17 07:35
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till extra bolagsstämma i XVIVO Perfusion Aktiebolag (publ)
2017-03-17 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
Styrelsen för XVIVO Perfusion beslutar om nyemission om högst ca. 181 miljoner kronor riktad till institutionella investerare
2017-03-17 07:30
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
The board of directors of XVIVO Perfusion resolves upon an up to approx. SEK 181 million share issue directed to institutional investors
2017-03-16 18:45
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
XVIVO Perfusion avser att genomföra en riktad emission av aktier
2017-03-16 18:45
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
XVIVO Perfusion intends to undertake a private placement of shares
2017-02-08 08:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion Report on Operations 2016
2017-02-08 08:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Yearend
Bokslutskommuniké 2016
2017-02-03 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2017-02-03 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2016-11-21 17:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion har godkänts för notering på Nasdaq Stockholm och offentliggör prospekt
2016-11-21 17:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion has been approved for listing on Nasdaq Stockholm and publishes prospectus
2016-10-27 17:15
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Clarification of news about two LS™ contract signed in Spain
2016-10-27 17:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Förtydligande angående två LS™ kontrakt i Spanien
2016-10-27 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion Interim report January – September 2016
2016-10-27 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Delårsrapport januari – september 2016
2016-10-27 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Två LS™ kontrakt i Spanien
2016-10-27 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Two LS™ contract signed in Spain
2016-10-21 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2016-10-21 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2016-09-20 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2016-09-20 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2016-07-15 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q2
XVIVO Perfusion Interim report January – June 2016
2016-07-15 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
Delårsrapport januari - juni 2016
2016-07-15 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Förlängd acceptperiod i XVIVO Perfusions bud på Vivoline Medical avslutad
2016-07-15 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Extension of the acceptance period of XVIVO Perfusion’s public offer on Vivoline Medical has ended
2016-07-08 09:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2016-07-08 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2016-07-08 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2016-07-08 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2016-06-22 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Lungcancerpatient ges kemoterapi genom In Vivo Lung perfusion med STEEN Solution™
2016-06-22 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Lung Cancer Patient given Chemotherapy through In Vivo Lung Perfusion with STEEN Solution™
2016-06-21 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion förlänger acceptperioden avseende budet på Vivoline Medical
2016-06-21 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion extends the acceptance period for the public offer on Vivoline Medical
2016-06-17 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ contract signed with leading hospital in Alabama
2016-06-17 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ kontrakt med klinik i Alabama
2016-06-15 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Första patienten i PrimECC studien inkluderad
2016-06-15 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
First patient in PrimECC study included
2016-06-08 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion declares the public offer on Vivoline Medical unconditional, announces the outcome and extends the acceptance period
2016-06-08 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion förklarar budet på Vivoline Medical ovillkorat, offentliggör utfallet och förlänger acceptperioden
2016-05-17 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call regarding information on the offer made to Vivoline’s shareholders
2016-05-17 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende Information angående Erbjudandet till Vivolines aktieägare
2016-05-10 14:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion published prospectus regarding the public offer to the holders of shares and warrants of series 2015/2016 in Vivoline Medical
2016-05-10 14:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion offentliggör prospekt avseende erbjudandet till ägare av aktier och teckningsoptioner av serie 2015/2016 i Vivoline Medical
2016-05-04 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual General Meeting of XVIVO Perfusion AB (publ)
2016-05-04 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2016-04-26 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Report
Interim
Q1
XVIVO Perfusion delårsrapport januari - mars 2016
2016-04-26 08:30
News
IR
English
Regulatory
Listing Regulation
Report
Interim
Q1
XVIVO Perfusion Interim report January – March 2016
2016-04-22 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2016-04-22 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2016-04-18 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion announces a recommended public offer to the holders of shares and warrants of series 2015/2016 in Vivoline Medical
2016-04-18 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion lämnar ett rekommenderat offentligt erbjudande till ägare av aktier och teckningsoptioner av serie 2015/2016 i Vivoline Medical
2016-04-15 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ contract signed with leading hospital in Boston
2016-04-15 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ kontrakt med klinik i Boston
2016-04-11 08:30
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2015
2016-04-11 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2015
2016-03-31 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2016-03-31 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2016-02-24 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ to be delivered to the first clinic in France
2016-02-24 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ levereras till första kliniken i Frankrike
2016-02-16 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
PERFADEX® and STEEN Solution™ approved in Russia
2016-02-16 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
PERFADEX® och STEEN Solution™ godkända i Ryssland
2016-02-05 16:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion AB upptas till handel på Nasdaq First North Premier
2016-02-05 16:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion AB admitted to trading on Nasdaq First North Premier
2016-02-04 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Yearend
Report on operations 2015
2016-02-04 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Yearend
Bokslutskommuniké 2015
2016-01-29 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ till Schweiz
2016-01-29 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ to Switzerland
2016-01-28 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations 2015
2016-01-28 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké 2015
2016-01-07 08:30
News
IR
English
Corporate Information
Other Corporate Information
PrimECC has been granted CE mark
2016-01-07 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
PrimECC har erhållit CE-märke
2015-12-23 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ to Germany
2015-12-23 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ till Tyskland
2015-12-08 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
XVIVO förstärker ledningsgruppen
2015-12-08 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
XVIVO strengthens management team
2015-11-26 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ godkänd i Kanada
2015-11-26 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ approved in Canada
2015-11-20 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
STEEN Solution™ approved in China
2015-11-20 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
STEEN Solution™ godkänt i Kina
2015-10-23 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Report
Interim
Q3
FÖRSTA LEVERTRANSPLANTATIONEN MED STEEN SOLUTION™ UTFÖRD UNDER KVARTALET
2015-10-23 08:30
News
IR
English
Regulatory
Listing Regulation
Report
Interim
Q3
FIRST LIVER TRANSPLANT WITH STEEN SOLUTION™ PERFORMED DURING THE QUARTER
2015-10-19 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on interim report
2015-10-19 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2015-10-08 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ till världens näst största lungtransplantationsklinik
2015-10-08 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ at the world’s second largest lung transplant clinic
2015-09-22 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2015-09-22 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2015-08-13 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
Delårsrapport januari-juni 2015
2015-08-13 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q2
Interim Report January – June 2015
2015-08-06 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Första levertransplantationen med STEEN Solution™
2015-08-06 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
First Liver transplant with STEEN Solution™ performed
2015-08-04 14:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2015-08-04 14:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on interim report
2015-08-03 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion installerar ytterligare två XPS™ i USA
2015-08-03 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion adds two more XPS™ installations in the U.S.
2015-07-02 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2015-07-02 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2015-04-23 17:23
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual General Meeting of XVIVO Perfusion AB (publ)
2015-04-23 17:20
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2015-04-22 08:30
News
IR
English
Regulatory
Listing Regulation
Report
Interim
Q1
Interim Report January - March 2015
2015-04-22 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Report
Interim
Q1
Delårsrapport januari - mars 2015
2015-04-14 14:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on interim report
2015-04-14 14:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2015-03-31 09:30
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2014
2015-03-31 09:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2014
2015-03-27 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
First XPS™ to southern Europe and continued success in the US
2015-03-27 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Första XPS™ till Sydeuropa och fortsatta framgångar i USA
2015-03-24 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
KALLELSE TILL ÅRSSTÄMMA I XVIVO PERFUSION AB (PUBL)
2015-03-24 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)
2015-03-20 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO har erhållit metodpatent för STEEN Solution™ i USA
2015-03-20 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO granted method patent for STEEN Solution™ in USA
2015-03-19 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Two XPS™ to Florida
2015-03-19 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Två XPS™ till Florida
2015-02-19 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ approved in Australia
2015-02-19 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ godkänd i Australien
2015-02-09 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Settlement between XVIVO and Vivoline
2015-02-09 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Uppgörelse mellan XVIVO och Vivoline
2015-02-05 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Yearend
STRONG GROWTH AND DOUBLED EBITDA EXKLUSIVE ONE-TIME EXPENSES
2015-02-05 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Yearend
HÖG TILLVÄXT OCH DUBBLERAD EBITDA EXKLUSIVE ENGÅNGSKOSTNADER
2015-02-04 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO Perfusion breaks new ground in Germany and Texas
2015-02-04 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO Perfusion bryter ny mark i Tyskland och Texas
2015-01-27 14:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké 2014
2015-01-27 14:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations 2014
2014-12-18 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Utfall i Skiljedom angående XVIVO Perfusions rättigheter till Vivoline-patent
2014-12-18 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Decision of the Arbitration Board regarding XVIVO Perfusion’s rights to the Vivoline patents
2014-11-20 16:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO obtains financing from Vinnova for cancer research
2014-11-20 16:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO får Vinnova–finansiering för cancerforskning
2014-10-24 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q3
FORTSATT STARK FÖRSÄLJNINGSTILLVÄXT SAMT FDA GODKÄNNANDE FÖR XPS™ OCH STEEN SOLUTION™
2014-10-24 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q3
CONTINUED STRONG SALES GROWTH AND FDA APPROVAL FOR XPS™ AND STEEN SOLUTION™
2014-10-17 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2014-10-17 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2014-10-16 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2014-10-16 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2014-09-30 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Installation av den första XPS™:en i Asien
2014-09-30 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Installation of the first XPS™ in Asia
2014-09-19 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO får Horizon 2020 finansiering
2014-09-19 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO receives Horizon 2020 funding
2014-08-13 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO har erhållit marknadsgodkännande för STEEN Solution™ och XPS™ av FDA
2014-08-13 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO has received market approval from the FDA for STEEN Solution™ and XPS™.
2014-08-13 08:29
News
IR
English
Regulatory
VPML
Report
Interim
Q2
CONTINUED STRONG SALES GROWTH AND SEK 73 MILLION PRIVATE PLACEMENT
2014-08-13 08:29
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
FORTSATT STARK FÖRSÄLJNINGSTILLVÄXT SAMT RIKTAD NYEMISSION OM 73 MSEK
2014-08-07 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2014-08-07 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2014-07-07 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2014-07-07 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2014-06-26 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO has completed a private placement of shares
2014-06-26 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
Xvivo genomför en riktad nyemission
2014-06-25 17:31
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO Perfusion AB avser att genomföra en riktad emission av aktier
2014-06-25 17:31
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO intends to undertake a private placement of shares
2014-04-30 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I XVIVO PERFUSION AB (PUBL)
2014-04-30 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
REPORT FROM ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)
2014-04-23 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q1
Delårsrapport januari – mars 2014
2014-04-23 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q1
Interim Report January - March 2014
2014-04-14 15:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2014-04-14 15:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2014-04-07 09:30
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2013
2014-04-07 09:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual report 2013
2014-03-31 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XPS™ systemet har erhållit CE-märke
2014-03-31 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XPS™ has received CE mark
2014-03-28 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)
2014-03-28 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
KALLELSE TILL ÅRSSTÄMMA I XVIVO PERFUSION AB (PUBL)
2014-03-21 08:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
FDA:s Expertpanelen röstade enhälligt för att XPS™ med STEEN Solution™ uppfyller kraven för HDE
2014-03-21 08:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
The FDA Advisory Panel voted unanimously that XPS™ with STEEN Solution™ meets the requirements for HDE
2014-03-14 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Progress made in the NOVEL study in the USA
2014-03-14 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Framsteg i NOVEL studien i USA
2014-02-07 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Yearend
Report on Operations 2013
2014-02-07 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Yearend
Bokslutskommuniké 2013
2014-01-29 14:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO expands the US study with another leading transplant center
2014-01-29 14:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO utökar USA-studien med ytterligare en ledande transplantationsklinik
2014-01-28 14:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké 2013
2014-01-28 14:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations 2013
2013-12-19 14:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Unikt samarbete mellan OPO och transplantationsklinik inledd i XVIVOs amerikanska studie
2013-12-19 14:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Unique collaboration between OPO and transplant center initiated in XVIVO’s US clinical trial
2013-11-07 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q3
Interim report January - September 2013
2013-11-07 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q3
Delårsrapport januari–september 2013
2013-11-06 11:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO utökar NOVEL studien i USA
2013-11-06 11:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO expands the NOVEL study in the USA
2013-10-29 10:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2013-10-29 10:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telekonferens avseende delårsrapport
2013-10-25 10:30
News
IR
English
Regulatory
VPML
Corporate Information
Staff change
Dr. Joel Cooper accepted to be new Medical Advisor to XVIVO perfusion
2013-10-25 10:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Presentation
Dr Joel Cooper ny Medical Advisor för XVIVO Perfusion
2013-10-18 10:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO lanserar XPS™ systemet i Europa
2013-10-18 10:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO launches the XPS™ system in Europe
2013-10-16 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2013-10-16 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2013-10-11 11:50
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO Perfusion files lawsuit against Vivoline
2013-10-11 11:50
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO Perfusion stämmer Vivoline
2013-09-20 16:55
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
NOVEL trial recruitment of patients complete, FDA has decided that an expert panel meeting will be held Q1 of 2014.
2013-09-20 16:55
News
IR
Swedish
Regulatory
VPML
Corporate Information
General meeting
Notice
STEEN Solution™ studien i USA färdigrekryterad, FDA har bestämt att ett expertmöte ska hållas i första kvartalet 2014.
2013-07-11 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
Delårsrapport januari–juni 2013
2013-07-11 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q2
Interim report January - June 2013
2013-07-09 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Samtliga patienter inkluderade i den amerikanska NOVEL studien med STEEN Solution™
2013-07-09 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
All patients included in the NOVEL trial in the USA with STEEN Solution™
2013-07-04 16:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2013-07-04 16:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2013-07-01 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telekonferens avseende delårsrapport
2013-07-01 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2013-05-08 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2013-05-08 08:30
News
IR
English
Regulatory
VPML
Corporate Information
General meeting
Report of the AGM
Report from Annual General Meeting of XVIVO Perfusion AB (publ)
2013-04-19 13:00
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q1
Delårsrapport januari–mars 2013
2013-04-19 13:00
News
IR
English
Regulatory
VPML
Report
Interim
Q1
Interim report January-March 2013
2013-04-15 14:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual report 2012
2013-04-15 14:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2012
2013-04-12 11:45
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Clarification of XVIVO Perfusion’s rights to Professor Stig Steen’s media for the preservation and evaluation of organs
2013-04-12 11:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Klarläggande XVIVO Perfusions rättigheter till Professor Stig Steens medier för preservation och evaluering av organ
2013-04-11 11:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2013-04-11 11:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telekonferens avseende delårsrapport
2013-04-08 15:00
News
IR
English
Regulatory
VPML
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2013-04-08 15:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
General meeting
Notice
Kallelse till årsstämma I XVIVO Perfusion AB (publ)
2013-02-19 16:30
News
IR
English
Regulatory
VPML
Report
Interim
Yearend
Report on operations 2012
2013-02-19 16:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Yearend
BOKSLUTSKOMMUNIKÉ 2012
2013-02-15 12:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telekonferens avseende bokslutskommuniké 2012
2013-02-15 12:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on the Report on Operations 2012
2013-02-07 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Ytterligare stämning mot Vitrolifes amerikanska dotterbolag rörande Perfadex
2013-02-07 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Further lawsuits filed against Vitrolife’s American subsidiary regarding Perfadex
2012-11-21 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Staff change
Ny Sälj- och Marknadsdirektör på XVIVO Perfusion
2012-11-21 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Staff change
New Sales and Marketing Director at XVIVO Perfusion
2012-11-08 13:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO Perfusion receives marketing approval for STEEN Solution™ in Canada.
2012-11-08 13:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO Perfusion erhåller försäljningsgodkännande för STEEN Solution™ i Kanada.
2012-11-01 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q3
Sammanfattning januari-september 2012
2012-11-01 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q3
Summary January-September 2012
2012-10-04 08:30
News
IR
English
Corporate Information
Other Corporate Information
Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012
2012-10-04 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Xvivo Perfusion AB upptas till handel på NASDAQ OMX First North den 8 oktober 2012.
2020 2019 2018 2017 2016 2015 2014 2013 2012
2020-09-23 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion avser att genomföra en riktad nyemission av aktier
2020-09-23 17:31
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion intends to carry out a directed issue of shares
2020-09-23 17:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion förvärvar det nederländska medicintekniska företaget Organ Assist och finansierar förvärvet genom en nyemission av aktier
2020-09-23 17:30
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion to acquire the Dutch medtech company Organ Assist and finances the acquisition through a private placement of new shares
2020-09-21 16:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
Changes in XVIVO Perfusion's Management Team
2020-09-21 16:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Förändringar i XVIVO Perfusions ledningsgrupp
2020-09-11 16:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till extra bolagsstämma i XVIVO Perfusion AB (publ)
2020-09-11 16:15
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice to attend the Extraordinary General Meeting in XVIVO Perfusion AB (publ)
2020-09-09 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Första patienten i PrimECC-studien inkluderad
2020-09-09 07:30
News
IR
English
Corporate Information
Other Corporate Information
First patient in the PrimECC study included
2020-09-04 11:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion stärker ledningsgruppen med ny Commercial Director och ny R&D Director
2020-09-04 11:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director
2020-07-10 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
I startblocken inför studieuppstart för hjärtpreservation och PrimECC
2020-07-10 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
In the starting blocks for heart preservation and PrimECC trial
2020-07-02 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2020-07-02 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2020-06-12 16:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Hjärtpreservations-studien från Lund publicerad i Nature Communications
2020-06-12 16:30
News
IR
English
Corporate Information
Other Corporate Information
The study from Lund published in Nature Communications
2020-05-19 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XPS™ säljs till en ledande lungtransplantationsklinik i Europa
2020-05-19 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XPS™ sold to a leading lung transplant clinic in Europe
2020-04-28 18:30
News
IR
English
Regulatory
MAR
Corporate Information
Staff change
Magnus Nilsson hands over the baton to Dag Andersson as President and CEO of XVIVO Perfusion
2020-04-28 18:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Staff change
Magnus Nilsson lämnar över stafettpinnen till Dag Andersson som vd och koncernchef för XVIVO Perfusion
2020-04-24 15:40
News
IR
Swedish
Corporate Information
Staff change
XVIVO utnämner ny IP-chef och ny Medicinsk chef
2020-04-24 15:40
News
IR
Swedish
Corporate Information
Staff change
XVIVO appoints a new IP manager and a new Medical Director
2020-04-09 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
Strong cash flow despite the influence of Covid-19
2020-04-09 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Starkt kassaflöde trots påverkan av Covid-19
2020-04-06 11:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport (uppdaterad länk)
2020-04-06 11:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report (link updated)
2020-04-02 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2020-04-02 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Conference call on Interim Report
2020-03-31 17:00
News
IR
Swedish
Regulatory
MAR
VPML
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2020-03-31 17:00
News
IR
English
Regulatory
MAR
VPML
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2020-03-31 09:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XPS™ såld till pediatrisk transplantationsklinik i Italien
2020-03-31 09:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XPS™ sold to pediatric transplantation clinic in Italy
2020-03-25 10:50
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Valberedningen föreslår oförändrade styrelsearvoden – justerad version
2020-03-25 10:50
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
The Nomination Committee proposes unchanged Board remuneration -adjusted version
2020-03-25 10:15
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
The Nomination Committee proposes unchanged Board remuneration
2020-03-25 10:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Valberedningen föreslår oförändrade styrelsearvoden
2020-03-25 08:30
News
IR
English
Regulatory
MAR
VPML
Corporate Information
Financial calendar
XVIVO Perfusion advances the date for submission of the January-March 2020 interim report
2020-03-25 08:30
News
IR
Swedish
Regulatory
MAR
VPML
Corporate Information
Financial calendar
XVIVO Perfusion tidigarelägger datum för avlämnande av delårsrapport för Januari-Mars 2020
2020-03-18 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Med anledning av Covid-19: XVIVO Perfusion AB:s årsstämma flyttas till ny adress och ytterligare försiktighetsåtgärder vidtas
2020-03-18 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
As a result of Covid-19: The Annual General Meeting of XVIVO Perfusion is moved to a new address and further precautions are taken
2020-03-18 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
COVID-19 EPIDEMINS PÅVERKAN PÅ XVIVO PERFUSION
2020-03-18 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
THE COVID-19 EFFECT ON XVIVO PERFUSION
2020-03-09 09:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2019
2020-03-09 09:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2019
2020-02-24 23:45
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice to attend the Annual General Meeting of XVIVO Perfusion AB (publ)
2020-02-24 23:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2020-01-30 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Yearend
A historic year ended with a quarter of sales records
2020-01-30 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Yearend
Kvartal med försäljningsrekord avslutar ett historiskt år
2020-01-24 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2020-01-24 08:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2019-12-16 11:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion har fått Breakthrough Device Designation beviljat från FDA för XVIVO Heart Preservation System
2019-12-16 11:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion granted Breakthrough Device Designation from the FDA for the XVIVO Heart Preservation System
2019-10-29 13:00
News
IR
English
Corporate Information
Other Corporate Information
Third XPS™ sold in Australia
2019-10-29 13:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Tredje XPS™ till i Australien
2019-10-24 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
Good growth and new important XPS clinics
2019-10-24 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
God tillväxt och viktiga nya XPS-kliniker
2019-10-23 16:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO opens a subsidiary in Australia
2019-10-23 16:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO öppnar ett dotterbolag i Australien
2019-10-23 13:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion AB (publ) issue of warrants of series 2019/2021 fully subscribed
2019-10-23 13:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion AB (publ) teckningsoptioner av serie 2019/2021 fulltecknat
2019-10-21 13:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2019-10-21 13:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2019-09-24 15:30
News
IR
Swedish
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2019-09-24 15:30
News
IR
English
Corporate Information
Nomination Committee
Nomination Committee of XVIVO Perfusion AB (publ)
2019-09-18 08:00
News
IR
English
Corporate Information
Other Corporate Information
XPS™ sold to China
2019-09-18 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XPS™ såld till Kina
2019-08-23 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Lung Bioengineering har köpt en XPS™ till deras nya EVLP center i Jacksonville
2019-08-23 08:00
News
IR
English
Corporate Information
Other Corporate Information
Lung Bioengineering has acquired the XPS™ for use in its new Jacksonville EVLP center
2019-08-21 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Perfadex® Plus has received patent approval in Europe
2019-08-21 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Perfadex Plus har erhållit patentgodkännande i Europa
2019-07-17 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO och MyCartis samarbetar inom utveckling av ett diagnostiskt test för att bedöma kvaliteten på donerade organ före transplantation
2019-07-17 08:30
News
IR
English
Corporate Information
Other Corporate Information
XVIVO and MyCartis engage to develop a fast diagnostic test to assess the quality of donated organs before transplantation
2019-07-12 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
HISTORISKT PMA-GODKÄNNANDE OCH FRAMSTEG I FoU-PORTFÖLJEN
2019-07-12 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
HISTORIC PMA APPROVAL AND PROGRESS IN THE R&D PORTFOLIO
2019-07-05 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2019-07-05 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2019-06-25 08:00
News
IR
English
Regulatory
VPML
Corporate Information
Financial calendar
XVIVO Perfusion changes the date of reporting of the Report on Operations 2019 to January 30, 2020
2019-06-25 08:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Financial calendar
XVIVO Perfusion tidigarelägger datum för rapportering av Bokslutskommuniké 2019 till den 30:e januari 2020.
2019-05-31 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2019-05-31 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2019-05-15 08:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO har erhållit klartecken från läkemedelsverket för kliniska studier med bolagets nya produkter för hjärtpreservation
2019-05-15 08:00
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO has received approval from the Swedish MPA to begin clinical studies with the company's new products for heart preservation
2019-05-03 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Första XPS™ såld till Kanada
2019-05-03 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
First XPS™ sold to Canada
2019-05-02 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVOs patent för hjärtpreservations-vätska godkända i USA och Europa
2019-05-02 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO’s patents for the heart preservation fluid approved in the US and Europe
2019-04-29 08:30
News
IR
English
Corporate Information
Other Corporate Information
XVIVO has received market approval (PMA) from the FDA for STEEN Solution™ and XPS™
2019-04-29 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO har erhållit marknadsgodkännande (PMA) för STEEN Solution™ och XPS™ av FDA
2019-04-27 00:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO has received market approval (PMA) from the FDA for STEEN Solution™ and XPS™
2019-04-27 00:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO har erhållit marknadsgodkännande (PMA) för STEEN Solution™ och XPS™ av FDA
2019-04-25 16:30
News
IR
English
Regulatory
MAR
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2019-04-25 16:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2019-04-24 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
STRONG GROWTH IN WARM PERFUSION AND PROGRESS IN THE R&D PORTFOLIO
2019-04-24 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
HÖG TILLVÄXT FÖR VARM PERFUSION OCH FRAMSTEG INOM FoU-PORTFÖLJEN
2019-04-23 17:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Resultat från hjärtpreservations-studien presenterat på ISHLT
2019-04-23 17:00
News
IR
English
Corporate Information
Other Corporate Information
Results from the heart preservation study presented on ISHLT
2019-04-16 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2019-04-16 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2019-04-02 12:00
News
IR
English
Regulatory
VPML
Report
Annual
Annual Report 2018
2019-04-02 12:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2018
2019-03-25 14:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
RÄTTELSE AV KALLELSE TILL ÅRSSTÄMMA I XVIVO PERFUSION AB (publ)
2019-03-25 14:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
AMENDMENT OF NOTICE TO ATTEND ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (publ)
2019-03-25 06:00
News
IR
Swedish
Corporate Information
Other Corporate Information
VD Magnus Nilsson har kvar lika många aktier som innan den 6 mars 2019
2019-03-25 06:00
News
IR
English
Corporate Information
Other Corporate Information
CEO Magnus Nilsson has the same number of shares as before March 6, 2019
2019-03-20 09:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2019-03-20 09:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2019-02-08 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion AB (publ) Bokslutskommuniké 2018
2019-02-08 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion AB (publ) Report on operations 2018
2019-02-04 11:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2019-02-04 11:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2019-01-15 16:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Information from XVIVO Perfusion´s Nomination Committee
2019-01-15 16:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Information från XVIVO Perfusions Valberedning
2018-12-07 13:30
News
IR
English
Corporate Information
Other Corporate Information
Professor Stig Steen’s heart preservation technology required for successful transplantation from pigs to baboons
2018-12-07 13:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Professor Stig Steens hjärtpreservationsteknologi en förutsättning för lyckade hjärttransplantationer från gris till babian
2018-10-26 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion AB (publ) delårsrapport januari – september 2018
2018-10-26 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion AB (publ) Interim Report January – September 2018
2018-10-17 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2018-10-17 15:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2018-09-24 15:30
News
IR
English
Corporate Information
Nomination Committee
Nomination Committee of XVIVO Perfusion AB (publ)
2018-09-24 15:30
News
IR
Swedish
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2018-07-20 08:00
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
Interim report January-June 2018
2018-07-20 08:00
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
Delårsrapport januari-juni 2018
2018-07-12 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2018-07-12 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2018-06-29 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2018-06-29 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2018-06-25 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Perfadex Plus godkänt av FDA
2018-06-25 10:00
News
IR
English
Corporate Information
Other Corporate Information
Perfadex Plus approved by the FDA
2018-06-14 20:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion changes the date of reporting of the interim report January - June 2018 to July 20, 2018
2018-06-14 20:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion ändrar datum för rapportering av delårsrapport januari – juni 2018 till den 20 juli 2018
2018-06-12 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
UNITED THERAPEUTICS OCH XVIVO PERFUSION INLEDER SAMARBETE FÖR ATT MINSKA ORGANBRISTEN GENOM UTÖKAD TJÄNST INOM ORGANUTVÄRDERING
2018-06-12 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
UNITED THERAPEUTICS AND XVIVO PERFUSION ANNOUNCE COLLABORATION TO REDUCE ORGAN SHORTAGE THROUGH EXPANSION OF ORGAN EVALUATION SERVICE
2018-06-05 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Xvivo Perfusion lanserar Perfadex Plus, en uppgraderad ready to use version av Perfadex
2018-06-05 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XVIVO Perfusion launches Perfadex Plus, an upgraded ready to use version of Perfadex
2018-05-14 14:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Positiva fynd i PrimECC®-studien
2018-05-14 14:00
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Positive findings in the PrimECC study
2018-05-11 06:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
PMA ansökan för STEEN Solution™ och XPS™ inlämnad till FDA
2018-05-11 06:00
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
PMA application for XPS™ with STEEN Solution™ submitted to the FDA
2018-04-27 14:40
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2018-04-27 14:40
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2018-04-26 07:00
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
XVIVO Perfusion AB (publ) delårsrapport januari – mars 2018
2018-04-26 07:00
News
IR
English
Regulatory
MAR
Report
Interim
Q1
XVIVO Perfusion AB (publ) Interim Report January – March 2018
2018-04-19 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2018-04-19 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2018-04-04 12:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2017
2018-04-04 12:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2017
2018-03-22 09:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2018-03-22 09:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2018-03-22 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Optionsprogram till VD och vice VD/CFO
2018-03-22 08:30
News
IR
English
Corporate Information
Other Corporate Information
Option program for the CEO and the deputy CEO
2018-03-08 15:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Information från XVIVO Perfusions Valberedning
2018-03-08 15:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Information from XVIVO Perfusion´s Nomination Committee
2018-02-09 08:00
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion AB (publ) Bokslutskommuniké 2017
2018-02-09 08:00
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion AB (publ) Report on Operations 2017
2018-02-05 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Ändrat datum för Telefonkonferens avseende bokslutskommuniké
2018-02-05 09:00
News
IR
English
Corporate Information
Other Corporate Information
Date changed for Conference call on Report on Operations
2018-02-01 15:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2018-02-01 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2017-12-01 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Första XPS™ installerad i Kina
2017-12-01 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
First XPS™ installed in China
2017-11-07 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Reimbursement-koder erhållna för hela EVLP processen i USA
2017-11-07 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Reimbursement codes obtained for doctor´s time during EVLP procedure
2017-10-27 08:00
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion (publ) Interim Report January – September 2017
2017-10-27 08:00
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion AB (publ) delårsrapport januari – september 2017
2017-10-20 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2017-10-20 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2017-09-21 14:30
News
IR
Swedish
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2017-09-21 14:30
News
IR
English
Corporate Information
Nomination Committee
Nomination Committee of XVIVO Perfusion AB (publ)
2017-09-12 14:40
News
IR
Swedish
Corporate Information
Other Corporate Information
Första hjärttransplantationen med Stig Steens nya metod genomförd på människa
2017-09-12 14:40
News
IR
English
Corporate Information
Other Corporate Information
First clinical heart transplant performed using Stig Steen’s new method
2017-07-17 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
XVIVO Perfusion´s CFO appointed Deputy CEO
2017-07-17 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
XVIVO Perfusions CFO utnämnd till vice VD
2017-07-14 08:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
Interim Report January – June 2017
2017-07-14 08:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
Delårsrapport januari – juni 2017
2017-07-13 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
PrimECC studien färdigrekryterad
2017-07-13 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Recruitment completed for PrimECC study
2017-07-10 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2017-07-10 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2017-07-06 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Recruitment completed for NOVEL study in the US on STEEN Solution™ and XPS™
2017-07-06 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
NOVEL-studien i USA med STEEN Solution™ och XPS™ färdigrekryterad
2017-06-30 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2017-06-30 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2017-04-28 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2017-04-28 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2017-04-26 17:17
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2017-04-26 17:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2017-04-25 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Delårsrapport januari – mars 2017
2017-04-25 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
Interim Report January – March 2017
2017-04-19 09:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2017-04-19 09:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2017-04-12 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
First XPS™ sold to Australia and to the Netherlands
2017-04-12 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Australien och Nederländerna nya länder med XPS™
2017-04-10 09:45
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
SUMMARY FROM EXTRAORDINARY GENERAL MEETING OF XVIVO PERFUSION AKTIEBOLAG (PUBL)
2017-04-10 09:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I XVIVO PERFUSION AKTIEBOLAG (PUBL)
2017-04-04 07:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2016
2017-04-04 07:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2016
2017-03-20 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2017-03-20 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2017-03-17 07:35
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice of Extraordinary General Meeting of XVIVO Perfusion Aktiebolag (publ)
2017-03-17 07:35
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till extra bolagsstämma i XVIVO Perfusion Aktiebolag (publ)
2017-03-17 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
Styrelsen för XVIVO Perfusion beslutar om nyemission om högst ca. 181 miljoner kronor riktad till institutionella investerare
2017-03-17 07:30
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
The board of directors of XVIVO Perfusion resolves upon an up to approx. SEK 181 million share issue directed to institutional investors
2017-03-16 18:45
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
XVIVO Perfusion avser att genomföra en riktad emission av aktier
2017-03-16 18:45
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
XVIVO Perfusion intends to undertake a private placement of shares
2017-02-08 08:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion Report on Operations 2016
2017-02-08 08:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Yearend
Bokslutskommuniké 2016
2017-02-03 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2017-02-03 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2016-11-21 17:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion har godkänts för notering på Nasdaq Stockholm och offentliggör prospekt
2016-11-21 17:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion has been approved for listing on Nasdaq Stockholm and publishes prospectus
2016-10-27 17:15
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Clarification of news about two LS™ contract signed in Spain
2016-10-27 17:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Förtydligande angående två LS™ kontrakt i Spanien
2016-10-27 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion Interim report January – September 2016
2016-10-27 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Delårsrapport januari – september 2016
2016-10-27 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Två LS™ kontrakt i Spanien
2016-10-27 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Two LS™ contract signed in Spain
2016-10-21 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2016-10-21 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2016-09-20 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2016-09-20 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2016-07-15 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q2
XVIVO Perfusion Interim report January – June 2016
2016-07-15 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
Delårsrapport januari - juni 2016
2016-07-15 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Förlängd acceptperiod i XVIVO Perfusions bud på Vivoline Medical avslutad
2016-07-15 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Extension of the acceptance period of XVIVO Perfusion’s public offer on Vivoline Medical has ended
2016-07-08 09:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2016-07-08 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2016-07-08 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2016-07-08 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2016-06-22 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Lungcancerpatient ges kemoterapi genom In Vivo Lung perfusion med STEEN Solution™
2016-06-22 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Lung Cancer Patient given Chemotherapy through In Vivo Lung Perfusion with STEEN Solution™
2016-06-21 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion förlänger acceptperioden avseende budet på Vivoline Medical
2016-06-21 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion extends the acceptance period for the public offer on Vivoline Medical
2016-06-17 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ contract signed with leading hospital in Alabama
2016-06-17 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ kontrakt med klinik i Alabama
2016-06-15 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Första patienten i PrimECC studien inkluderad
2016-06-15 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
First patient in PrimECC study included
2016-06-08 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion declares the public offer on Vivoline Medical unconditional, announces the outcome and extends the acceptance period
2016-06-08 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion förklarar budet på Vivoline Medical ovillkorat, offentliggör utfallet och förlänger acceptperioden
2016-05-17 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call regarding information on the offer made to Vivoline’s shareholders
2016-05-17 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende Information angående Erbjudandet till Vivolines aktieägare
2016-05-10 14:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion published prospectus regarding the public offer to the holders of shares and warrants of series 2015/2016 in Vivoline Medical
2016-05-10 14:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion offentliggör prospekt avseende erbjudandet till ägare av aktier och teckningsoptioner av serie 2015/2016 i Vivoline Medical
2016-05-04 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual General Meeting of XVIVO Perfusion AB (publ)
2016-05-04 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2016-04-26 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Report
Interim
Q1
XVIVO Perfusion delårsrapport januari - mars 2016
2016-04-26 08:30
News
IR
English
Regulatory
Listing Regulation
Report
Interim
Q1
XVIVO Perfusion Interim report January – March 2016
2016-04-22 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2016-04-22 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2016-04-18 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion announces a recommended public offer to the holders of shares and warrants of series 2015/2016 in Vivoline Medical
2016-04-18 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion lämnar ett rekommenderat offentligt erbjudande till ägare av aktier och teckningsoptioner av serie 2015/2016 i Vivoline Medical
2016-04-15 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ contract signed with leading hospital in Boston
2016-04-15 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ kontrakt med klinik i Boston
2016-04-11 08:30
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2015
2016-04-11 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2015
2016-03-31 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2016-03-31 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2016-02-24 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ to be delivered to the first clinic in France
2016-02-24 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ levereras till första kliniken i Frankrike
2016-02-16 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
PERFADEX® and STEEN Solution™ approved in Russia
2016-02-16 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
PERFADEX® och STEEN Solution™ godkända i Ryssland
2016-02-05 16:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion AB upptas till handel på Nasdaq First North Premier
2016-02-05 16:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion AB admitted to trading on Nasdaq First North Premier
2016-02-04 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Yearend
Report on operations 2015
2016-02-04 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Yearend
Bokslutskommuniké 2015
2016-01-29 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ till Schweiz
2016-01-29 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ to Switzerland
2016-01-28 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations 2015
2016-01-28 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké 2015
2016-01-07 08:30
News
IR
English
Corporate Information
Other Corporate Information
PrimECC has been granted CE mark
2016-01-07 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
PrimECC har erhållit CE-märke
2015-12-23 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ to Germany
2015-12-23 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ till Tyskland
2015-12-08 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
XVIVO förstärker ledningsgruppen
2015-12-08 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
XVIVO strengthens management team
2015-11-26 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ godkänd i Kanada
2015-11-26 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ approved in Canada
2015-11-20 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
STEEN Solution™ approved in China
2015-11-20 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
STEEN Solution™ godkänt i Kina
2015-10-23 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Report
Interim
Q3
FÖRSTA LEVERTRANSPLANTATIONEN MED STEEN SOLUTION™ UTFÖRD UNDER KVARTALET
2015-10-23 08:30
News
IR
English
Regulatory
Listing Regulation
Report
Interim
Q3
FIRST LIVER TRANSPLANT WITH STEEN SOLUTION™ PERFORMED DURING THE QUARTER
2015-10-19 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on interim report
2015-10-19 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2015-10-08 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ till världens näst största lungtransplantationsklinik
2015-10-08 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ at the world’s second largest lung transplant clinic
2015-09-22 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2015-09-22 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2015-08-13 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
Delårsrapport januari-juni 2015
2015-08-13 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q2
Interim Report January – June 2015
2015-08-06 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Första levertransplantationen med STEEN Solution™
2015-08-06 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
First Liver transplant with STEEN Solution™ performed
2015-08-04 14:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2015-08-04 14:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on interim report
2015-08-03 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion installerar ytterligare två XPS™ i USA
2015-08-03 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion adds two more XPS™ installations in the U.S.
2015-07-02 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2015-07-02 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2015-04-23 17:23
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual General Meeting of XVIVO Perfusion AB (publ)
2015-04-23 17:20
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2015-04-22 08:30
News
IR
English
Regulatory
Listing Regulation
Report
Interim
Q1
Interim Report January - March 2015
2015-04-22 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Report
Interim
Q1
Delårsrapport januari - mars 2015
2015-04-14 14:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on interim report
2015-04-14 14:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2015-03-31 09:30
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2014
2015-03-31 09:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2014
2015-03-27 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
First XPS™ to southern Europe and continued success in the US
2015-03-27 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Första XPS™ till Sydeuropa och fortsatta framgångar i USA
2015-03-24 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
KALLELSE TILL ÅRSSTÄMMA I XVIVO PERFUSION AB (PUBL)
2015-03-24 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)
2015-03-20 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO har erhållit metodpatent för STEEN Solution™ i USA
2015-03-20 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO granted method patent for STEEN Solution™ in USA
2015-03-19 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Two XPS™ to Florida
2015-03-19 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Två XPS™ till Florida
2015-02-19 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ approved in Australia
2015-02-19 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ godkänd i Australien
2015-02-09 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Settlement between XVIVO and Vivoline
2015-02-09 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Uppgörelse mellan XVIVO och Vivoline
2015-02-05 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Yearend
STRONG GROWTH AND DOUBLED EBITDA EXKLUSIVE ONE-TIME EXPENSES
2015-02-05 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Yearend
HÖG TILLVÄXT OCH DUBBLERAD EBITDA EXKLUSIVE ENGÅNGSKOSTNADER
2015-02-04 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO Perfusion breaks new ground in Germany and Texas
2015-02-04 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO Perfusion bryter ny mark i Tyskland och Texas
2015-01-27 14:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké 2014
2015-01-27 14:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations 2014
2014-12-18 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Utfall i Skiljedom angående XVIVO Perfusions rättigheter till Vivoline-patent
2014-12-18 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Decision of the Arbitration Board regarding XVIVO Perfusion’s rights to the Vivoline patents
2014-11-20 16:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO obtains financing from Vinnova for cancer research
2014-11-20 16:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO får Vinnova–finansiering för cancerforskning
2014-10-24 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q3
FORTSATT STARK FÖRSÄLJNINGSTILLVÄXT SAMT FDA GODKÄNNANDE FÖR XPS™ OCH STEEN SOLUTION™
2014-10-24 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q3
CONTINUED STRONG SALES GROWTH AND FDA APPROVAL FOR XPS™ AND STEEN SOLUTION™
2014-10-17 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2014-10-17 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2014-10-16 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2014-10-16 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2014-09-30 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Installation av den första XPS™:en i Asien
2014-09-30 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Installation of the first XPS™ in Asia
2014-09-19 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO får Horizon 2020 finansiering
2014-09-19 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO receives Horizon 2020 funding
2014-08-13 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO har erhållit marknadsgodkännande för STEEN Solution™ och XPS™ av FDA
2014-08-13 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO has received market approval from the FDA for STEEN Solution™ and XPS™.
2014-08-13 08:29
News
IR
English
Regulatory
VPML
Report
Interim
Q2
CONTINUED STRONG SALES GROWTH AND SEK 73 MILLION PRIVATE PLACEMENT
2014-08-13 08:29
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
FORTSATT STARK FÖRSÄLJNINGSTILLVÄXT SAMT RIKTAD NYEMISSION OM 73 MSEK
2014-08-07 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2014-08-07 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2014-07-07 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2014-07-07 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2014-06-26 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO has completed a private placement of shares
2014-06-26 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
Xvivo genomför en riktad nyemission
2014-06-25 17:31
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO Perfusion AB avser att genomföra en riktad emission av aktier
2014-06-25 17:31
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO intends to undertake a private placement of shares
2014-04-30 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I XVIVO PERFUSION AB (PUBL)
2014-04-30 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
REPORT FROM ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)
2014-04-23 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q1
Delårsrapport januari – mars 2014
2014-04-23 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q1
Interim Report January - March 2014
2014-04-14 15:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2014-04-14 15:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2014-04-07 09:30
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2013
2014-04-07 09:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual report 2013
2014-03-31 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XPS™ systemet har erhållit CE-märke
2014-03-31 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XPS™ has received CE mark
2014-03-28 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)
2014-03-28 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
KALLELSE TILL ÅRSSTÄMMA I XVIVO PERFUSION AB (PUBL)
2014-03-21 08:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
FDA:s Expertpanelen röstade enhälligt för att XPS™ med STEEN Solution™ uppfyller kraven för HDE
2014-03-21 08:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
The FDA Advisory Panel voted unanimously that XPS™ with STEEN Solution™ meets the requirements for HDE
2014-03-14 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Progress made in the NOVEL study in the USA
2014-03-14 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Framsteg i NOVEL studien i USA
2014-02-07 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Yearend
Report on Operations 2013
2014-02-07 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Yearend
Bokslutskommuniké 2013
2014-01-29 14:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO expands the US study with another leading transplant center
2014-01-29 14:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO utökar USA-studien med ytterligare en ledande transplantationsklinik
2014-01-28 14:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké 2013
2014-01-28 14:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations 2013
2013-12-19 14:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Unikt samarbete mellan OPO och transplantationsklinik inledd i XVIVOs amerikanska studie
2013-12-19 14:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Unique collaboration between OPO and transplant center initiated in XVIVO’s US clinical trial
2013-11-07 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q3
Interim report January - September 2013
2013-11-07 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q3
Delårsrapport januari–september 2013
2013-11-06 11:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO utökar NOVEL studien i USA
2013-11-06 11:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO expands the NOVEL study in the USA
2013-10-29 10:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2013-10-29 10:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telekonferens avseende delårsrapport
2013-10-25 10:30
News
IR
English
Regulatory
VPML
Corporate Information
Staff change
Dr. Joel Cooper accepted to be new Medical Advisor to XVIVO perfusion
2013-10-25 10:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Presentation
Dr Joel Cooper ny Medical Advisor för XVIVO Perfusion
2013-10-18 10:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO lanserar XPS™ systemet i Europa
2013-10-18 10:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO launches the XPS™ system in Europe
2013-10-16 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2013-10-16 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2013-10-11 11:50
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO Perfusion files lawsuit against Vivoline
2013-10-11 11:50
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO Perfusion stämmer Vivoline
2013-09-20 16:55
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
NOVEL trial recruitment of patients complete, FDA has decided that an expert panel meeting will be held Q1 of 2014.
2013-09-20 16:55
News
IR
Swedish
Regulatory
VPML
Corporate Information
General meeting
Notice
STEEN Solution™ studien i USA färdigrekryterad, FDA har bestämt att ett expertmöte ska hållas i första kvartalet 2014.
2013-07-11 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
Delårsrapport januari–juni 2013
2013-07-11 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q2
Interim report January - June 2013
2013-07-09 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Samtliga patienter inkluderade i den amerikanska NOVEL studien med STEEN Solution™
2013-07-09 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
All patients included in the NOVEL trial in the USA with STEEN Solution™
2013-07-04 16:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2013-07-04 16:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2013-07-01 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telekonferens avseende delårsrapport
2013-07-01 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2013-05-08 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2013-05-08 08:30
News
IR
English
Regulatory
VPML
Corporate Information
General meeting
Report of the AGM
Report from Annual General Meeting of XVIVO Perfusion AB (publ)
2013-04-19 13:00
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q1
Delårsrapport januari–mars 2013
2013-04-19 13:00
News
IR
English
Regulatory
VPML
Report
Interim
Q1
Interim report January-March 2013
2013-04-15 14:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual report 2012
2013-04-15 14:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2012
2013-04-12 11:45
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Clarification of XVIVO Perfusion’s rights to Professor Stig Steen’s media for the preservation and evaluation of organs
2013-04-12 11:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Klarläggande XVIVO Perfusions rättigheter till Professor Stig Steens medier för preservation och evaluering av organ
2013-04-11 11:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2013-04-11 11:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telekonferens avseende delårsrapport
2013-04-08 15:00
News
IR
English
Regulatory
VPML
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2013-04-08 15:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
General meeting
Notice
Kallelse till årsstämma I XVIVO Perfusion AB (publ)
2013-02-19 16:30
News
IR
English
Regulatory
VPML
Report
Interim
Yearend
Report on operations 2012
2013-02-19 16:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Yearend
BOKSLUTSKOMMUNIKÉ 2012
2013-02-15 12:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telekonferens avseende bokslutskommuniké 2012
2013-02-15 12:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on the Report on Operations 2012
2013-02-07 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Ytterligare stämning mot Vitrolifes amerikanska dotterbolag rörande Perfadex
2013-02-07 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Further lawsuits filed against Vitrolife’s American subsidiary regarding Perfadex
2012-11-21 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Staff change
Ny Sälj- och Marknadsdirektör på XVIVO Perfusion
2012-11-21 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Staff change
New Sales and Marketing Director at XVIVO Perfusion
2012-11-08 13:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO Perfusion receives marketing approval for STEEN Solution™ in Canada.
2012-11-08 13:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO Perfusion erhåller försäljningsgodkännande för STEEN Solution™ i Kanada.
2012-11-01 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q3
Sammanfattning januari-september 2012
2012-11-01 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q3
Summary January-September 2012
2012-10-04 08:30
News
IR
English
Corporate Information
Other Corporate Information
Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012
2012-10-04 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Xvivo Perfusion AB upptas till handel på NASDAQ OMX First North den 8 oktober 2012.